Estrella Immunopharma ESLA Balance Sheet (2021-2026)

NASDAQ ESLA
$0.75 +0.01 (+1.35%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
0.32M0.48M0.32M0.09M0.07M0.04M0.03M2.48M22.14M9.05M4.70M4.17M1.80M0.92M0.42M1.30M1.60M1.38M1.93M0.15M
Cash & Current Investments (Quarter)
0.32M0.48M0.32M0.09M0.07M0.04M0.03M2.48M22.14M9.05M4.70M4.17M1.80M0.92M0.42M1.30M1.60M1.38M1.93M0.15M
Receivables - Net (Quarter)
0.27M0.27M
Receivables (Quarter)
0.27M0.27M
Prepaid Assets (Quarter)
0.01M0.14M0.11M0.04M0.09M0.01M0.05M0.09M0.14M0.40M0.41M0.29M0.44M0.72M0.52M0.16M0.40M0.29M0.23M0.18M
Current Assets (Quarter)
0.78M0.62M0.43M0.13M0.16M0.05M0.08M2.75M9.45M8.63M4.45M2.24M1.64M0.94M1.48M2.02M1.68M2.16M1.82M
Non-Current Assets
Long-Term Investments (Quarter)
45.19M45.19M45.19M45.26M45.46M9.67M9.70M9.79M5.10M0.05M0.05M0.05M0.05M
Long-Term Deferred Tax (Quarter)
0.26M0.28M
Other Non-Current Assets (Quarter)
2.75M27.35M1.50M1.50M1.50M1.50M1.50M1.50M1.50M
Non-Current Assets (Quarter)
45.19M45.19M45.19M45.26M45.46M9.67M9.70M0.28M1.50M1.50M1.50M1.50M1.50M1.50M1.50M
Assets (Quarter)
45.97M45.80M45.62M45.38M45.62M9.72M9.78M3.03M27.35M9.45M8.63M4.45M3.74M3.14M2.44M2.98M3.52M3.18M3.66M1.82M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
0.00M0.00M0.01M0.11M0.21M0.33M0.38M9.33M9.34M0.08M0.01M0.00M0.01M0.01M0.01M0.50M0.01M0.01M
Notes Payables (Quarter)
0.50M0.14M0.27M0.30M0.19M0.39M0.36M0.47M0.69M
Payables (Quarter)
0.00M0.00M0.01M0.11M0.71M0.33M0.51M9.61M9.64M0.08M0.01M0.00M0.01M0.20M0.39M0.86M0.48M0.70M
Accumulated Expenses (Quarter)
0.40M0.00M0.27M0.17M0.13M0.00M0.01M0.12M0.11M0.00M0.06M0.00M0.26M
Other Accumulated Expenses (Quarter)
0.02M0.02M0.00M391.00347.000.00M0.01M0.00M0.02M0.00M0.00M
Short term Debt (Quarter)
0.05M
Current Taxes (Quarter)
0.05M0.09M0.00M5.07M0.04M0.04M0.04M0.04M50.0050.00
Total Current Liabilities (Quarter)
0.10M0.07M0.03M0.15M0.74M1.07M1.22M9.76M17.28M0.40M0.14M0.18M2.99M3.00M4.28M9.08M13.36M13.54M8.93M9.30M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter)
45.19M45.19M45.19M45.19M45.32M9.33M9.54M9.75M
Non-Current Deferred Tax Liability (Quarter)
0.03M0.01M0.01M
Other Non-Current Liabilities (Quarter)
0.01M0.32M0.19M0.39M0.36M0.47M0.69M
Total Non-Current Liabilities (Quarter)
0.01M17.28M0.40M0.14M0.18M2.99M2.68M8.89M12.97M13.19M8.46M8.57M
Total Liabilities (Quarter)
1.65M1.62M1.58M1.71M2.29M2.65M2.77M9.77M17.28M0.40M0.14M0.18M2.99M3.00M4.28M9.08M13.36M13.54M8.93M9.26M
Shareholder's Equity
Total Debt (Quarter)
0.05M
Common Equity (Quarter)
-0.87M-1.01M-1.15M-1.04M-3.82M-6.48M-9.11M-11.74M10.07M9.05M8.49M4.27M0.75M0.14M-1.83M-6.09M-9.84M-10.37M-5.27M-7.43M
Liabilities and Shareholders Equity (Quarter)
45.97M45.80M45.62M45.38M45.62M9.72M9.78M3.03M27.35M9.45M8.63M4.45M3.74M3.14M2.44M2.98M3.52M3.18M3.66M1.82M
Treasury Shares (Quarter)
4.43M4.43M4.43M4.43M4.43M0.91M0.91M0.07M0.32M0.43M2.21M0.52M0.52M0.52M0.52M10.18M9.81M
Retained Earnings (Quarter)
-0.87M-1.01M-1.15M-1.51M-1.98M-2.26M-2.53M-12.19M-14.06M-15.10M-15.50M-19.50M-22.90M24.64M-26.00M-31.58M-36.38M27.22M34.61M-41.60M
Preferred Shares (Quarter)
5.00M0.50M0.50M0.50M0.50M